Forskrifter
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
FDA
MHRA
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO-liste
Kliniske studier
US Clinical Trials Registry
EUs kliniske prøveregister
Farmasøytiske selskaper
Clinical Research Labs
Tjenestebedrifter
Clinical Research Events
Publikasjoner
Forskere
Arbeidsplasser
Publikasjoner
Nyheter
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til
engelsk versjon
for en kildetekst.
ICH GCP
US Clinical Trials Registry
Search trials
Tilstand eller sykdom:
Intervensjon/behandling:
Sponsor:
Plassering:
Kun rekruttering og ennå ikke rekrutteringsstudier
Clinical Trials on Hyperbilirubinemi in Chile
Totalt 1 resultater
Cirujanos la Serena
Fullført
Hyperbilirubinemi i akutt blindtarmbetennelse som en prediktor for perforering
Perforert blindtarmbetennelse
Chile
Sponsorer og samarbeidspartnere
Douglas Johnson
Cambridge Antibody Technology
Vanderbilt Institute for Clinical and Translational Research (CTSA)
Cheng-Hsin General Hospital
Danish University Antidepressant Group
Translate Bio, Inc.
Bay Hematology Oncology PA, Easton MD
Medical Health Research Infrastructure Council, Australia
Mutual Pension Insurance Company Ilmarinen
Universidad de Almeria
dr. Riana Pauline Tamba, SpB(K)BA
Instituto de Oftalmología Fundación Conde de Valenciana
Compass Therapeutics
Sun Ten Pharmaceutical Co., Ltd.
Swiss School of Public Health (SSPH+)
HRB Stroke Trials Network Ireland
Interventional Spine, Inc.
Lumen Therapeutics
Institut Raoul Follereau
CICbioGUNE
Vis full liste
Medisinsk tilstand
Q feber
Vaksine mot gul feber
Akutt spinal lammelse
Vurdering Evaluering
Covid-19 (SARS-CoV-2)
Intimalt sarkom
Postoperative stater
Nodal Marginal Zone B-celle lymfom
Papilleødem
Kroniske trykksår
Beta-laktammerallergi
Mengde postoperativ opioidbruk i milligram
Muskelanstrengt lår
Preoperativ optimalisering
Nesidioblastose
Somatiske symptomer
Antinøytrofil cytoplasmatisk antistoffassosiert vaskulitt
Traumatiske hjerneskader NPO i minst 12 timer
Implementation of a Chronic Disease Management Programme
CVD risikofaktorer
Vis full liste
Legemiddelintervensjoner
Abatacept
RT001 Botulinumtoksin type A (dose A)
Som indikert: Sertralin, bupropion, venlafaksin, mirtazepin, nortriptylin, tranylcypromin, litiumforsterkning, etc.
LTC004 + MIL-97+kjemoterapi
SinuSurf vanning to ganger daglig
MoviPrep
Del 2 gruppe D (Pindolol)
Talaporfinnatrium
Mykofenolsyre
Tranexamic Acid 500 mg tablett
Nefopam Høy dose
SAR407899A
Papaverin
Propofol
SCI-110
Dasatinib
NP-016 vaksine immunglobulin (IV-VIG)
Fostamatinib
Gabapentin
Nivolumab
Vis full liste
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Algeria
Contract Research Organizations in Colombia
Contract Research Organizations in Germany
Contract Research Organizations in Greece
Contract Research Organizations in Guatemala
Contract Research Organizations in Indonesia
Contract Research Organizations in Malawi
Contract Research Organizations in Philippines
Contract Research Organizations in Senegal
Contract Research Organizations in Slovenia
Contract Research Organizations in South Korea
Contract Research Organizations in Thailand
CRO list by country
CROs in Argentina
LatinaBA
EGCP S.A. (Excellence in Good Clinical Practice)
ICON
PPD
CLINERGY Health Research
Syneos Health
Estudios Clínicos Latinoamérica (ECLA)
Fortrea
Caidya
KLIXAR
All CROs in Argentina
3
✕
GOOD CLINICAL PRACTICE NETWORK
Abonner for å motta varsler om reguleringsoppdateringer og bransjenyheter!
Abonnere
GOOD CLINICAL PRACTICE NETWORK
Abonner for å motta varsler om reguleringsoppdateringer og bransjenyheter!
Abonnere
Abonnere